
BACKGROUND Lower-limb muscle strength and gait performance are key physical functions, but regional differences in their association remain unclear. METHODS This cross-sectional study included 164 community-dwelling Mongolian adults aged ≥50 years (33 men, 131 women) from rural Mandalgovi and urban Ulaanbaatar. Isometric knee extension torque (Nm/kg) was measured. Gait performance was assessed using a 10-m walk test under comfortable and maximal conditions. Sex-stratified multiple regression analyses included a muscle strength × region interaction term, adjusting for age and BMI. RESULTS In men, muscle strength was significantly associated with comfortable (B=0.46, p=0.003) and maximal gait speed (B=0.85, p < 0.001). Significant muscle strength × region interactions were observed for maximal gait speed (p=0.044) and step count (p=0.045). Region-specific analyses indicated stronger associations in Mandalgovi (R2=0.72) than Ulaanbaatar (R2=0.18). In women, muscle strength was significantly associated with all gait outcomes, with no significant interaction. CONCLUSIONS Regional differences modified the association between lower-limb muscle strength and gait performance in men but not women; given the small male subsample, this finding is considered preliminary, suggesting the potential importance of region-specific approaches for maintaining physical function in older Mongolian adults.
BACKGROUND The role of endovascular treatment (EVT) in middle cerebral artery M2 segment occlusion remains inconclusive, particularly in rural areas with aging populations. We characterized EVT and medical management (MM) for M2 occlusion in Fukushima Prefecture, Japan, and explored clinical factors associated with outcomes. METHODS We analyzed a prospective multicenter acute ischemic stroke registry (July 2020-June 2022; 11 stroke centers). Patients with M2 occlusion were classified into EVT or MM groups; characteristics, workflow metrics, and outcomes were described and referenced against previously reported series. RESULTS Among 210 patients, 34 had M2 occlusion (EVT, n=10; MM, n=24). At 90 days, functional independence (modified Rankin Scale [mRS] 0-2) was 40.0% (EVT) and 45.8% (MM); symptomatic intracerebral hemorrhage, 0% and 4.2%; mortality, 20.0% and 12.5%; successful reperfusion, 70.0% (EVT). Both groups were older than in previous reports (median 81 years). The EVT group also received rt-PA less often (30.0%) and had longer puncture-to-reperfusion times (81 minutes), whereas the MM group had lower pre-stroke independence (67%) and higher mortality, despite lower severity. CONCLUSION Advanced age, delayed reperfusion, and greater pre-stroke dependency distinguished this rural cohort from previous reports and likely account for its outcomes, underscoring the need for locally tailored patient selection for EVT in M2 occlusion.
Microscopic polyangiitis (MPA), a form of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), can involve skeletal muscle. However, vasculitic myopathy remains underrecognized, and no consensus has been established regarding its optimal management. A 67-year-old Japanese man presented with progressive myalgia predominantly affecting the lower extremities. Laboratory evaluation revealed elevated inflammatory markers and myeloperoxidase-ANCA positivity, while serum creatine kinase levels remained within the normal range. Thigh magnetic resonance imaging (MRI) demonstrated diffuse hyperintensity on short tau inversion recovery sequences involving the quadriceps muscles. Muscle biopsy revealed inflammatory cell infiltration with fibrinoid necrosis in small vessels, confirming the diagnosis of vasculitic myopathy associated with MPA. Remission was achieved with induction therapy using glucocorticoids and rituximab, followed by maintenance therapy with avacopan. Subsequent MRI showed complete resolution of muscular abnormalities, and sustained clinical remission was maintained without relapse. This case demonstrates the utility of MRI for the early detection of MPA-associated vasculitic myopathy and for assessing treatment response, and suggests that avacopan may be a promising option for remission maintenance in this condition.